New chip may pick better sperm for IVF, study hopes to find out

NCT ID NCT07093619

Recruiting now Knowledge-focused Sponsor: ART Fertility Clinics LLC Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares a new microfluidic sperm-sorting chip (FERTILE Plus) to the standard density gradient method for preparing sperm used in IVF with genetic testing (PGT-A). Researchers will measure how long each method takes and whether embryos made with chip-sorted sperm are more likely to be chromosomally normal. The trial enrolls 100 women undergoing IVF, using a split-sample design so each sperm sample is processed both ways.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: FERTILE Plus microfluidic sperm sorting chip
What this could lead to: If microfluidic sperm preparation proves faster and yields more chromosomally normal embryos, it could become a standard technique in IVF labs, potentially improving success rates.
What could go wrong: This is a small, early-stage study (100 participants) comparing two lab methods. Even if microfluidics shows benefits here, results may not translate to higher live birth rates or apply to all fertility cases.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ICSI are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ICSI PGT-A SEMEN ANALYSIS

Contacts and locations

Locations

ART Fertility Clinics LLC
RECRUITING

Abu Dhabi, Abu Dhabi Emirate, 60202, United Arab Emirates

More trials for these conditions

Other studies related to the condition(s) this trial covers.